Urinary proteins detected using modern proteomics intervene in early type 2 diabetic kidney disease - a pilot study

Biomark Med. 2020 Nov;14(16):1521-1536. doi: 10.2217/bmm-2020-0308. Epub 2020 Oct 22.

Abstract

Aim: An advanced proteomics platform for protein biomarker discovery in diabetic chronic kidney disease (DKD) was developed, validated and implemented. Materials & methods: Three Type 2 diabetes mellitus patients and three control subjects were enrolled. Urinary peptides were extracted, samples were analyzed on a hybrid LTQ-Orbitrap Velos Pro instrument. Raw data were searched using the SEQUEST algorithm and integrated into Proteome Discoverer platform. Results & discussion: Unique peptide sequences, resulted sequence coverage, scoring of peptide spectrum matches were reported to albuminuria and databases. Five proteins that can be associated with early DKD were found: apolipoprotein AI, neutrophil gelatinase-associated lipocalin, cytidine deaminase, S100-A8 and hemoglobin subunit delta. Conclusion: Urinary proteome analysis could be used to evaluate mechanisms of pathogenesis of DKD.

Keywords: albuminuria; diabetes mellitus Type 2; inflammation; proximal tubule dysfunction; urinary proteomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Albuminuria / diagnosis
  • Albuminuria / urine
  • Biomarkers / urine
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetes Mellitus, Type 2 / urine
  • Diabetic Nephropathies / diagnosis*
  • Diabetic Nephropathies / urine
  • Female
  • Humans
  • Kidney Diseases / diagnosis
  • Kidney Diseases / urine
  • Kidney Function Tests
  • Male
  • Middle Aged
  • Peptides
  • Pilot Projects
  • Proteome / analysis
  • Proteomics / methods

Substances

  • Biomarkers
  • Peptides
  • Proteome